Objective
The technology that will arise from INRECA is generic and can be applied to numerous domains where case history is available. The objectives of INRECA+ are: further integrate induction and case-based reasoning technologies in a generic software tool for developing diagnostic and decision support systems from historical databases; integrate new component technologies in INRECA such as fuzzy logic, nearest neighbour search and rule-based reasoning and enhance case acquisition tools with multimedia support; validate the methodology and the system on real applications that deal with diagnosis in the medical and pharmaceutical domains; transfer technology developed in the NIS (NIS) to INTAS participants and initiate a long-term scientific and technical collaboration between Western European and NIS participants of INRECA+.
Case-based reasoning (CBR) is a technology that finds analogies between a current working case and past experiences in historical databases (reference cases). Induction is a technology that automatically extracts knowledge from training cases in the form of a decision tree or a set of rules. Induction and CBR are complementary technologies that provide methodologies for knowledge acquisition, validation and maintenance of decision support systems that are based on experience. INRECA has shown how the two approaches are complementary and is integrating them in a unified software system.
INRECA+ will build upon the results of INRECA and add new functionalities for hypermedia support, new CBR functionalities that were developed in Moscow, add fuzzy logic components whose theoretical validation has been conducted in Moldavia, and validate the resulting system on a number of medical and pharmaceutical applications with real users in Russia, Ukraine and Belarus. In the course of the project at least three types of applications will be considered, including: diagnosis and monitoring of diseases that were caused by the Chernobyl accident, pulmonary diseases, abdominal pains and coma caused by heart diseases; training of practioners in hospitals by helping to transfer the experience of the most talented specialists to those less experienced; identification of analogies between case report forms for handling adverse events when testing new drugs before their introduction on the market (clinical trials in the pharmaceutical domain). INRECA+ will further contribute to the creation of a European standard for case-based reasoning and case data representation.
Topic(s)
Call for proposal
Data not availableFunding Scheme
Data not availableCoordinator
75013 Paris
France